1
|
Amal L, Wend-Yam Mohamed T, Kaoutar I, Hounayda J, Rachida L, Youssef O. Leptomeningeal Metastasis Mimicking a Subacute Epidural Hematoma: Case Report. CLINICAL MEDICINE INSIGHTS-CASE REPORTS 2022; 15:11795476221121315. [PMID: 36091424 PMCID: PMC9452806 DOI: 10.1177/11795476221121315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Accepted: 08/05/2022] [Indexed: 11/15/2022]
Abstract
Leptomeningeal carcinomatosis is extremely rare in colorectal adenocarcinoma, its incidence is far less than 1%. The neurological symptoms are pleomorphic. The most common symptoms included Headache, ataxia, cranial nerve palsies, meningismus, focal weakness or numbness. MRI is the most sensitive and specific imaging method for screening, positive diagnosis and pre-treatment of leptomeningeal carcinomatosis. The presence of appropriate neuroimaging abnormalities in a patient with typical clinical features and history of colorectal adenocarcinoma enables to make the diagnosis of leptomeningeal metastases. As well as a biological confirmation is necessary. Treatment usually comprises site-specific radiation therapy in addition to intrathecal and systemic chemotherapy. The case aims to describe the MRI characteristics of leptomeningeal metastases so as to formulate the diagnosis and the subsequent treatment.
Collapse
Affiliation(s)
- Lahfidi Amal
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| | - Traore Wend-Yam Mohamed
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| | - Imrani Kaoutar
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| | - Jerguigue Hounayda
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| | - Latib Rachida
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| | - Omor Youssef
- Department of Radiology, Oncology National Institue, UHC Ibn Sina, Rabat, Morocco.,Université Mohammed V, Faculté de médecine et de pharmacie, Rabat, Maroc
| |
Collapse
|
3
|
Stoppek AK, Kebir S, Junker A, Keyvani K, Zülow S, Lazaridis L, Schmidt T, Pierscianek D, Stuschke M, Sure U, Kleinschnitz C, Scheffler B, Zimmer L, Glas M. Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case report. BMC Cancer 2019; 19:995. [PMID: 31646997 PMCID: PMC6813083 DOI: 10.1186/s12885-019-6183-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2019] [Accepted: 09/20/2019] [Indexed: 11/29/2022] Open
Abstract
Background Leptomeningeal metastasis (LM) is a predominantly late stage, devastating complication of a variety of malignant solid tumors. Diagnosis relies predominantly on neurological, radiographic, and cerebrospinal fluid (CSF) assessments. Recently, liquid biopsy tests derived from CSF has shown to be a feasible, noninvasive promising approach to tumor molecular profiling for proper brain cancer diagnostic treatment, thereby providing an opportunity for CSF-based personalized medicine. However, LM is typically misleadingly assumed to originate from only one primary tumor type. Case presentation In this case report, we provide first evidence of the co-occurrence of LM originating from more than one primary tumor types. Discussion and conclusions Based on this patient case profile, the co-occurrence of LM from two or more primary tumor types should be accounted for when deriving diagnostic conclusions from liquid biopsy tests.
Collapse
Affiliation(s)
- Ann-Kathrin Stoppek
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.,West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Sied Kebir
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.,West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,DKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ); German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Andreas Junker
- Institute of Neuropathology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Kathy Keyvani
- Institute of Neuropathology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Stefan Zülow
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Lazaros Lazaridis
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.,West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Teresa Schmidt
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.,West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Daniela Pierscianek
- West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Martin Stuschke
- Department of Radiotherapy, University Hospital Essen, Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Ulrich Sure
- West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Christoph Kleinschnitz
- Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Björn Scheffler
- DKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ); German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany
| | - Lisa Zimmer
- West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany.,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany.,Department of Dermatology, University Hospital, University Duisburg-Essen, Germany & German Cancer Consortium (DKTK), Heidelberg, Germany
| | - Martin Glas
- Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. .,West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Essen, Germany. .,German Cancer Consortium, Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. .,DKFZ Division of Translational Neurooncology at the West German Cancer Center (WTZ); German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Hufelandstr. 55, 45147, Essen, Germany. .,Department of Neurology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.
| |
Collapse
|